. 2019 Oct; 48(2):277-294.
doi: 10.1177/0192623319881401.

Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology

Oliver C Turner 1 Famke Aeffner 2 Dinesh S Bangari 3 Wanda High 4 Brian Knight 5 Tom Forest 6 Brieuc Cossic 7 Lauren E Himmel 8 Daniel G Rudmann 9 Bhupinder Bawa 10 Anantharaman Muthuswamy 11 Olulanu H Aina 11 Elijah F Edmondson 12 Chandrassegar Saravanan 13 Danielle L Brown 14 Tobias Sing 15 Manu M Sebastian 16 
  • PMID: 31645203
  •     6 citations


Toxicologic pathology is transitioning from analog to digital methods. This transition seems inevitable due to a host of ongoing social and medical technological forces. Of these, artificial intelligence (AI) and in particular machine learning (ML) are globally disruptive, rapidly growing sectors of technology whose impact on the long-established field of histopathology is quickly being realized. The development of increasing numbers of algorithms, peering ever deeper into the histopathological space, has demonstrated to the scientific community that AI pathology platforms are now poised to truly impact the future of precision and personalized medicine. However, as with all great technological advances, there are implementation and adoption challenges. This review aims to define common and relevant AI and ML terminology, describe data generation and interpretation, outline current and potential future business cases, discuss validation and regulatory hurdles, and most importantly, propose how overcoming the challenges of this burgeoning technology may shape toxicologic pathology for years to come, enabling pathologists to contribute even more effectively to answering scientific questions and solving global health issues. [Box: see text].

Keywords: artificial intelligence; deep learning; digital toxicologic pathology; machine learning; neural networks.

A Regulatory Science Initiative to Harmonize and Standardize Digital Pathology and Machine Learning Processes to Speed up Clinical Innovation to Patients.
Hetal Desai Marble, Richard Huang, +14 authors, Jochen K Lennerz.
J Pathol Inform, 2020 Oct 13; 11. PMID: 33042601    Free PMC article.
The Use of Quantitative Digital Pathology to Measure Proteoglycan and Glycosaminoglycan Expression and Accumulation in Healthy and Diseased Tissues.
A Sally Davis, Mary Y Chang, +5 authors, Charles W Frevert.
J Histochem Cytochem, 2020 Sep 17; 69(2). PMID: 32936035    Free PMC article.
Evaluation of the Use of Single- and Multi-Magnification Convolutional Neural Networks for the Determination and Quantitation of Lesions in Nonclinical Pathology Studies.
Jogile Kuklyte, Jenny Fitzgerald, +14 authors, Donal O'Shea.
Toxicol Pathol, 2021 Feb 24; 49(4). PMID: 33618634    Free PMC article.
Using Artificial Intelligence to Detect, Classify, and Objectively Score Severity of Rodent Cardiomyopathy.
Debra A Tokarz, Thomas J Steinbach, +10 authors, Torrie A Crabbs.
Toxicol Pathol, 2020 Dec 09; 49(4). PMID: 33287662    Free PMC article.
Artificial Intelligence in Digital Pathology: What Is the Future? Part 1: From the Digital Slide Onwards.
Maria Rosaria Giovagnoli, Daniele Giansanti.
Healthcare (Basel), 2021 Aug 07; 9(7). PMID: 34356236    Free PMC article.
Artificial Intelligence in Digital Pathology: What Is the Future? Part 2: An Investigation on the Insiders.
Maria Rosaria Giovagnoli, Sara Ciucciarelli, Livia Castrichella, Daniele Giansanti.
Healthcare (Basel), 2021 Oct 24; 9(10). PMID: 34683027    Free PMC article.